
Low Dose Naltrexone
he first person to study naltrexone in low doses for its off-label indications was a gentleman by the name of Dr. Bernard Bihari.

he first person to study naltrexone in low doses for its off-label indications was a gentleman by the name of Dr. Bernard Bihari.

You are likely to have thought about stealing a kiss underneath the mistletoe but using it to treat cancer, unlikely!

Whether you’ve had cancer, have cancer, or know someone with cancer, I bet this thought has crossed your mind: Is cancer just code word for


If cancer is a disease of energy metabolism – and not of mutated genes, then we need to shift our treatment focus there.



Are statins really the answer? The answer is NO!

Americans are exposed to a mind-numbing list of environmental toxicities on the daily, which originate from endless sources and significantl